These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 341532

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Comparative evaluation of the effectiveness of insulin preparations "Lente GP" and "Insulong" in type 1 diabetes mellitus].
    Kudriakova SV, Belovanova IM, Romanovskaia GA, Kasymov UA.
    Sov Med; 1991; (9):75-7. PubMed ID: 1798933
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Human ultralente insulin: a comparison with porcine lente insulin as a twice-daily insulin in insulin-dependent diabetic patients with fasting hyperglycaemia.
    Francis AJ, Hanning I, Alberti KG.
    Diabetes Res; 1986 Jun; 3(5):263-8. PubMed ID: 3527523
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intermediate-acting insulin preparations: NPH and lente.
    Deckert T.
    Diabetes Care; 1980 Jun; 3(5):623-6. PubMed ID: 7192205
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The antigenicity of various new chromatographically purified depot insulin preparations].
    Graber D, Fankhauser S.
    Schweiz Med Wochenschr; 1978 Nov 18; 108(46):1807-9. PubMed ID: 715418
    [Abstract] [Full Text] [Related]

  • 14. Comparison of injection techniques for soluble and protamine zinc insulins in diabetes mellitus.
    Harrower AD, Duncan LJ, Clarke BF.
    Practitioner; 1975 Feb 18; 214(1280):228-31. PubMed ID: 1144249
    [Abstract] [Full Text] [Related]

  • 15. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K, Giolitti A, Turco GL, Benedetto P, Bruni B.
    Minerva Med; 1975 Mar 14; 66(19):909-30. PubMed ID: 1124144
    [Abstract] [Full Text] [Related]

  • 16. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D, Iavicoli M, Colletti A, Menzinger G.
    Folia Endocrinol; 1972 Dec 14; 25(6):516-39. PubMed ID: 4581824
    [No Abstract] [Full Text] [Related]

  • 17. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S, Barbero PL, Bollati C, Castellazzi R, D'Adda A, Bruni B.
    Minerva Dietol Gastroenterol; 1979 Dec 14; 25(3):309-14. PubMed ID: 400003
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Immunogenicity of MC Lente Novo insulin].
    Rogala H, Lawecki J, Czyzyk A.
    Pol Arch Med Wewn; 1986 Sep 14; 76(3):172-6. PubMed ID: 3554163
    [No Abstract] [Full Text] [Related]

  • 20. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
    Bruni B, Gamba S, Regis G, Turco GL.
    Diabetologia; 1978 Mar 14; 14(3):165-9. PubMed ID: 566232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.